financetom
Business
financetom
/
Business
/
Market Chatter: Nasdaq, NYSE in Talks With SEC to Relax Listing Rules
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Nasdaq, NYSE in Talks With SEC to Relax Listing Rules
Jun 25, 2025 4:57 AM

07:44 AM EDT, 06/25/2025 (MT Newswires) -- Nasdaq (NDAQ) and the New York Stock Exchange are in ongoing talks with the US Securities and Exchange Commission to ease regulatory requirements for public companies to attract more high-value startups to go public, Reuters reported Wednesday, citing four unnamed sources familiar with the matter.

The discussions, which have reportedly been underway for months, include proposals to reduce disclosure obligations, cut the costs of going public and limit the influence of minority investors on corporate decisions.

Some experts view the talks as the most significant potential regulatory overhaul since the 2012 Jumpstart Our Business Startups Act and a continuation of deregulatory trends from the Trump era, according to the report.

NYSE General Counsel Jaime Klima told Reuters the exchange "strongly" believes effective and efficient regulation is essential to maintaining market appeal.

An SEC spokesperson said that the agency is considering relaxing rules that undermine capital formation, with the aim of ensuring "initial public offerings are again something companies are eager to do."

Nasdaq did not immediately respond to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck pauses Gardasil shipments to China, hitting its 2025 outlook
Merck pauses Gardasil shipments to China, hitting its 2025 outlook
Feb 4, 2025
* Gardasil pause to China began this month * Sales of Keytruda were over $7.8 billion in Q4, compared with analyst forecast of $7.4 billion * Gardasil sales were $1.55 billion, compared with analyst forecast of $1.8 billion By Michael Erman Feb 4 (Reuters) - Merck ( MRK ) said it will pause shipments of Gardasil to China through at...
CorVel's Fiscal Q3 Earnings, Revenue Rise
CorVel's Fiscal Q3 Earnings, Revenue Rise
Feb 4, 2025
06:26 AM EST, 02/04/2025 (MT Newswires) -- CorVel ( CRVL ) reported fiscal Q3 earnings Tuesday of $0.46 per diluted share, up from $0.33 a year earlier. Revenue for the quarter ended Dec. 31 was $228.0 million compared with $202.3 million a year earlier. No analyst estimates were available for comparison. ...
PepsiCo's Fiscal Q4 Core Earnings Rise, Revenue Falls; Provides Fiscal 2025 Guidance
PepsiCo's Fiscal Q4 Core Earnings Rise, Revenue Falls; Provides Fiscal 2025 Guidance
Feb 4, 2025
06:27 AM EST, 02/04/2025 (MT Newswires) -- PepsiCo ( PEP ) reported fiscal Q4 core earnings Tuesday of $1.96 per diluted share, up from $1.78 a year earlier. Analysts polled by FactSet expected $1.94. Revenue for the quarter ended Dec. 28 was $27.78 billion compared with $27.85 billion a year earlier. Analysts surveyed by FactSet expected $27.89 billion. The company...
Spotify Technology Swings to Q4 Earnings as Revenue Rises
Spotify Technology Swings to Q4 Earnings as Revenue Rises
Feb 4, 2025
06:26 AM EST, 02/04/2025 (MT Newswires) -- Spotify Technology SA ( SPOT ) reported Q4 diluted earnings Tuesday of 1.76 euros ($1.82) per share, swinging from a loss of 0.36 euros a year earlier. Analysts polled by FactSet expected earnings of 1.99 euros per share. Revenue for the quarter ended Dec. 31 was 4.24 billion euros, up from 3.67 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved